AusPAR: Human papillomavirus vaccine types 16 and 18 (recombinant AS04 adjuvanted)
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
6 January 2016
| AusPAR | |
|---|---|
| Active Ingredient | Human papillomavirus vaccine types 16 and 18 (recombinant AS04 adjuvanted)
|
| Product Name | Cervarix
|
| Sponsor | GlaxoSmithKline Australia Pty Ltd
|
| Submission Number | PM-2014-01893-1-2
|
| Submission Type | Major variation
|
| Decision | Approved
|
| AusPAR Date | 4 January 2016
|
| Publication Date | 6 January 2016 |